CANY
CELG

Caxton Associates (New York)’s Celgene Corp CELG Stock Holding History

Caxton Associates (New York)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,600
Closed -$468K – 675
2017
Q2 		$468K Buy
+3,600
New +$441K 0.02% 364

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Caxton Associates (New York)'s CELG Position: Q3 2017 in Review

Caxton Associates (New York) sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 3,600 shares — an estimated $468K sold.

Caxton Associates (New York) first reported a position in CELG in Q2 2017 and held it in 1 quarter. The position peaked at $468K in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Caxton Associates (New York) reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,600 Celgene Corp shares in Q3 2017, an estimated $468K.
  • Caxton Associates (New York) first reported a position in Celgene Corp in Q2 2017 and held it in 1 quarter.
  • Caxton Associates (New York)'s Celgene Corp position peaked at $468K in Q2 2017.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Caxton Associates (New York)'s 13F filing for Q3 2017, filed 14 Nov 2017.